TITCK (Turkey)
NOTICE
İLAÇ FİRMALARININ DİKKATİNE - 5337
Published: 7/31/2026Detected: 8/1/2026
Summary preview
RD/2026/7/2 RUHSAT BAŞVURUSU ÖNCESİ KATI ORAL DOZAJ FORMLARINDAKİ BEŞERİ TIBBİ ÜRÜNLERİN SERİ BOYUTU DEĞERLENDİRME KILAVUZU HAKKINDA DUYURU.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountOfficial Source Document Source Verified
Access the original document directly from TITCK.